N-terminal-pro brain natriuretic peptide in assessing the severity of stable coronary artery disease

Vijetha Shenoy Belle, R. V.Krishnananda Prabhu, Ranjan K. Shetty, Rajaram Prasad, Pragna Rao, Asha Kamath, Kriti Singh, Priyanka Datta

Research output: Contribution to journalArticle

Abstract

Introduction: Coronary Artery Disease (CAD) occurs due to atherosclerosis which results in progressive narrowing of coronary artery lumen. N-Terminal pro Brain Natriuretic Peptide (NT-proBNP) has been used as a marker of heart failure. However, its role in stable coronary artery disease without left ventricular dysfunction is limited. Aim: To measure and compare the serum NT-proBNP levels in stable coronary artery patients and controls and to correlate serum NT-proBNP levels with severity of CAD. Materials and Methods: The present study was conducted in Department of Biochemistry in collaboration with Department of Cardiology Kasturba Medical College, Manipal after the approval from Institutional Ethics Committee. A written consent was obtained from 86 study subjects (controls 36, cases 50). Serum NT-proBNP was measured using ELISA kit. Severity of CAD was graded by angiogram based Gensini scoring system. Mann-Whitney U-tests and spearman’s correlations were used. Serum NT-proBNP was expressed in median and interquartile range. The p-value<0.05 was considered to be significant. Results: Median values of serum NT-proBNP levels in cases (151.9 pg/mL) were significantly higher as compared to that of controls (99.31 pg/mL), (p<0.001). There was a significant positive correlation of serum NT-proBNP with the respective Gensini scores in patients with stable coronary artery disease (r=0.263, p=0.014). Conclusion: As Serum NT-proBNP levels were significantly associated with severity of stable CAD without left ventricular dysfunction, it can be a potential tool in effective management of stable CAD.

Original languageEnglish
Pages (from-to)BC25-BC28
JournalJournal of Clinical and Diagnostic Research
Volume12
Issue number8
DOIs
Publication statusPublished - 01-08-2018

Fingerprint

Brain Natriuretic Peptide
Coronary Artery Disease
Serum
Left Ventricular Dysfunction
Coronary Vessels
Cardiology
Ethics Committees
Biochemistry
Nonparametric Statistics
Atherosclerosis
Angiography
Heart Failure
Enzyme-Linked Immunosorbent Assay

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

Belle, Vijetha Shenoy ; Prabhu, R. V.Krishnananda ; Shetty, Ranjan K. ; Prasad, Rajaram ; Rao, Pragna ; Kamath, Asha ; Singh, Kriti ; Datta, Priyanka. / N-terminal-pro brain natriuretic peptide in assessing the severity of stable coronary artery disease. In: Journal of Clinical and Diagnostic Research. 2018 ; Vol. 12, No. 8. pp. BC25-BC28.
@article{9d63ebd3f00b4ad6b8beadbaa385643e,
title = "N-terminal-pro brain natriuretic peptide in assessing the severity of stable coronary artery disease",
abstract = "Introduction: Coronary Artery Disease (CAD) occurs due to atherosclerosis which results in progressive narrowing of coronary artery lumen. N-Terminal pro Brain Natriuretic Peptide (NT-proBNP) has been used as a marker of heart failure. However, its role in stable coronary artery disease without left ventricular dysfunction is limited. Aim: To measure and compare the serum NT-proBNP levels in stable coronary artery patients and controls and to correlate serum NT-proBNP levels with severity of CAD. Materials and Methods: The present study was conducted in Department of Biochemistry in collaboration with Department of Cardiology Kasturba Medical College, Manipal after the approval from Institutional Ethics Committee. A written consent was obtained from 86 study subjects (controls 36, cases 50). Serum NT-proBNP was measured using ELISA kit. Severity of CAD was graded by angiogram based Gensini scoring system. Mann-Whitney U-tests and spearman’s correlations were used. Serum NT-proBNP was expressed in median and interquartile range. The p-value<0.05 was considered to be significant. Results: Median values of serum NT-proBNP levels in cases (151.9 pg/mL) were significantly higher as compared to that of controls (99.31 pg/mL), (p<0.001). There was a significant positive correlation of serum NT-proBNP with the respective Gensini scores in patients with stable coronary artery disease (r=0.263, p=0.014). Conclusion: As Serum NT-proBNP levels were significantly associated with severity of stable CAD without left ventricular dysfunction, it can be a potential tool in effective management of stable CAD.",
author = "Belle, {Vijetha Shenoy} and Prabhu, {R. V.Krishnananda} and Shetty, {Ranjan K.} and Rajaram Prasad and Pragna Rao and Asha Kamath and Kriti Singh and Priyanka Datta",
year = "2018",
month = "8",
day = "1",
doi = "10.7860/JCDR/2018/35594.11939",
language = "English",
volume = "12",
pages = "BC25--BC28",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "8",

}

N-terminal-pro brain natriuretic peptide in assessing the severity of stable coronary artery disease. / Belle, Vijetha Shenoy; Prabhu, R. V.Krishnananda; Shetty, Ranjan K.; Prasad, Rajaram; Rao, Pragna; Kamath, Asha; Singh, Kriti; Datta, Priyanka.

In: Journal of Clinical and Diagnostic Research, Vol. 12, No. 8, 01.08.2018, p. BC25-BC28.

Research output: Contribution to journalArticle

TY - JOUR

T1 - N-terminal-pro brain natriuretic peptide in assessing the severity of stable coronary artery disease

AU - Belle, Vijetha Shenoy

AU - Prabhu, R. V.Krishnananda

AU - Shetty, Ranjan K.

AU - Prasad, Rajaram

AU - Rao, Pragna

AU - Kamath, Asha

AU - Singh, Kriti

AU - Datta, Priyanka

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Introduction: Coronary Artery Disease (CAD) occurs due to atherosclerosis which results in progressive narrowing of coronary artery lumen. N-Terminal pro Brain Natriuretic Peptide (NT-proBNP) has been used as a marker of heart failure. However, its role in stable coronary artery disease without left ventricular dysfunction is limited. Aim: To measure and compare the serum NT-proBNP levels in stable coronary artery patients and controls and to correlate serum NT-proBNP levels with severity of CAD. Materials and Methods: The present study was conducted in Department of Biochemistry in collaboration with Department of Cardiology Kasturba Medical College, Manipal after the approval from Institutional Ethics Committee. A written consent was obtained from 86 study subjects (controls 36, cases 50). Serum NT-proBNP was measured using ELISA kit. Severity of CAD was graded by angiogram based Gensini scoring system. Mann-Whitney U-tests and spearman’s correlations were used. Serum NT-proBNP was expressed in median and interquartile range. The p-value<0.05 was considered to be significant. Results: Median values of serum NT-proBNP levels in cases (151.9 pg/mL) were significantly higher as compared to that of controls (99.31 pg/mL), (p<0.001). There was a significant positive correlation of serum NT-proBNP with the respective Gensini scores in patients with stable coronary artery disease (r=0.263, p=0.014). Conclusion: As Serum NT-proBNP levels were significantly associated with severity of stable CAD without left ventricular dysfunction, it can be a potential tool in effective management of stable CAD.

AB - Introduction: Coronary Artery Disease (CAD) occurs due to atherosclerosis which results in progressive narrowing of coronary artery lumen. N-Terminal pro Brain Natriuretic Peptide (NT-proBNP) has been used as a marker of heart failure. However, its role in stable coronary artery disease without left ventricular dysfunction is limited. Aim: To measure and compare the serum NT-proBNP levels in stable coronary artery patients and controls and to correlate serum NT-proBNP levels with severity of CAD. Materials and Methods: The present study was conducted in Department of Biochemistry in collaboration with Department of Cardiology Kasturba Medical College, Manipal after the approval from Institutional Ethics Committee. A written consent was obtained from 86 study subjects (controls 36, cases 50). Serum NT-proBNP was measured using ELISA kit. Severity of CAD was graded by angiogram based Gensini scoring system. Mann-Whitney U-tests and spearman’s correlations were used. Serum NT-proBNP was expressed in median and interquartile range. The p-value<0.05 was considered to be significant. Results: Median values of serum NT-proBNP levels in cases (151.9 pg/mL) were significantly higher as compared to that of controls (99.31 pg/mL), (p<0.001). There was a significant positive correlation of serum NT-proBNP with the respective Gensini scores in patients with stable coronary artery disease (r=0.263, p=0.014). Conclusion: As Serum NT-proBNP levels were significantly associated with severity of stable CAD without left ventricular dysfunction, it can be a potential tool in effective management of stable CAD.

UR - http://www.scopus.com/inward/record.url?scp=85051143045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051143045&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2018/35594.11939

DO - 10.7860/JCDR/2018/35594.11939

M3 - Article

VL - 12

SP - BC25-BC28

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 8

ER -